Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Talia Flanagan"'
Autor:
Tom de Waal, Joachim Brouwers, Philippe Berben, Talia Flanagan, Jan Tack, Wim Vandenberghe, Tim Vanuytsel, Patrick Augustijns
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1243 (2023)
Parkinson’s disease, one of the most common neurodegenerative diseases, may not only affect the motor system, but also the physiology of the gastrointestinal tract. Delayed gastric emptying, impaired motility and altered intestinal bacteria are wel
Externí odkaz:
https://doaj.org/article/6520c5337e32421e88bc1d230ca741d8
Autor:
Mark McAllister, Talia Flanagan, Susan Cole, Andreas Abend, Evangelos Kotzagiorgis, Jobst Limberg, Heather Mead, Victor Mangas-Sanjuan, Paul A. Dickinson, Andrea Moir, Xavier Pepin, Diansong Zhou, Christophe Tistaert, Aristides Dokoumetzidis, Om Anand, Maxime Le Merdy, David B. Turner, Brendan T. Griffin, Adam Darwich, Jennifer Dressman, Claire Mackie
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1010 (2022)
A webinar series that was organised by the Academy of Pharmaceutical Sciences Biopharmaceutics focus group in 2021 focused on the challenges of developing clinically relevant dissolution specifications (CRDSs) for oral drug products. Industrial scien
Externí odkaz:
https://doaj.org/article/ef6f2c994c1b4a04809bf2645feb40a0
Autor:
Mark McAllister, Talia Flanagan, Karin Boon, Xavier Pepin, Christophe Tistaert, Masoud Jamei, Andreas Abend, Evangelos Kotzagiorgis, Claire Mackie
Publikováno v:
Pharmaceutics, Vol 12, Iss 1, p 19 (2019)
A meeting that was organized by the Academy of Pharmaceutical Sciences Biopharmaceutics and Regulatory Sciences focus groups focused on the challenges of Developing Clinically Relevant Dissolution Specifications (CRDS) for Oral Drug Products. Industr
Externí odkaz:
https://doaj.org/article/d563840c12884c1e841c153027ac2f11
Publikováno v:
Biopharmaceutics. :147-163
Autor:
Hannah Batchelor, Talia Flanagan
Publikováno v:
Biopharmaceutics. :135-146
Autor:
Matthew E. Popkin, Markus Goese, Diane Wilkinson, Stuart Finnie, Talia Flanagan, Cristiana Campa, Alexandra Clinch, Andrew Teasdale, Andrew Lennard, Graham Cook, Ganapathy Mohan, Matthew D. Osborne
Publikováno v:
The AAPS journal. 24(6)
This publication provides some industry reflections on experiences from the Chemistry, Manufacturing, and Controls (CMC) development and manufacture and supply of vaccines and therapies in response to the COVID-19 pandemic. It integrates these experi
Autor:
Evangelos Kotzagiorgis, Shinichi Kijima, Om Anand, Yang Zhao, Sandra Suarez-Sharp, Talia Flanagan, Min Li, Baoming Ning, Poonam Delvadia, Shefali Kakar, Amitava Mitra, Greg Rullo, Jennifer B. Dressman, Neil Parrott, Erik Sjögren, Banu S. Zolnik, Shereeni Veerasingham, Paul A. Dickinson, Gustavo Mendes Lima Santos, Tycho Heimbach, Haritha Mandula, Christophe Tistaert, Fang Wu, Kimberly Raines, Satish Sharan, Xavier Pepin, Andrew Babiskin
Publikováno v:
Journal of Pharmaceutical Sciences. 110:594-609
This report summarizes the proceedings for Day 3 of the workshop titled "Current State and Future Expectations of Translational Modeling Strategies toSupportDrug Product Development, Manufacturing Changes and Controls". From a drug product quality pe
Autor:
Alex Mattinson, David Lindley, Helena Engman, Manthena V.S. Varma, Anh-Thu Nguyen-Trung, Binfeng Xia, Xavier Pepin, Linette Ruston, Wei Zhu, Bill van Osdol, Celine Ollier, David Good, Jonathan Brown, Laurent Boulu, Talia Flanagan, Olivier Nicolas, Staffan Berg, Shanoo Budhdeo, Aarti Patel, Jan Bevernage, Handan He, Sweta Modi, Richard Barker, Claire Jackson, Christer Tannergren, Xiojun Ren, Stephane Beilles, J. Matthew Wood, Johanna Laru, Pierre Daublain, Sara Carlert, Louis Henrion, Jean-Flaubert Nguefack, Gunilla Hanisch, Eva Karlsson, Wen Lin, Shruthi Vaidhyanathan, Robert Carr, Fan Wu, Jin Zhang, Amais Ahmad, James M. Mullin, Sari Pappinen, Andrea Moir, Ke Szeto, Christine Xu, Claire Patterson, David B. Turner, Guillaume Louit, Yuya Wang, Tycho Heimbach, Richard Lloyd, Frans Franek, Masoud Jamei, Christophe Tistaert, Bertil Abrahamsson, Kerstin Julia Schäfer, Leon Aarons, Shriram M. Pathak, Adam S. Darwich, Suet Wong, Dónal Murphy, Amin Rostami-Hodjegan, Timo Korjamo, Helena Thörn, Kartrin Schmid, Michael B. Bolger, Johanna Tuunainen, Mai Anh Nguyen
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 156:50-63
Oral drug absorption is a complex process depending on many factors, including the physicochemical properties of the drug, formulation characteristics and their interplay with gastrointestinal physiology and biology. Physiological-based pharmacokinet
Autor:
Marilyn N. Martinez, Balint Sinko, Fang Wu, Talia Flanagan, Enikő Borbás, Eleftheria Tsakalozou, Kathleen M. Giacomini
Publikováno v:
The AAPS journalReferences. 24(3)
Traditionally, excipients have been considered in drug development from the perspective of their influence on drug solubility, manufacturability, and ability to control in vitro and in vivo drug release. These effects have been largely evaluated thro
Autor:
Jennifer B. Dressman, Sakina Sayah-Jeanne, James Mann, Talia Flanagan, Eva Karlsson, Domagoj Segregur, Matthias Hoch, David J. Carlile, Andrea Moir
Publikováno v:
Journal of Pharmaceutical Sciences. 108:3461-3477
Background Of the various drug therapies that influence gastrointestinal (GI) physiology, one of the most important are the acid-reducing agents (ARAs). Because changes in GI physiology often influence the pharmacokinetics of drugs given orally, ther